Show simple item record

dc.contributor.authorPrice, David
dc.contributor.authorRyan, Dermot
dc.contributor.authorBurden, Annie
dc.contributor.authorVon Ziegenweidt, Julie
dc.contributor.authorGould, Shuna
dc.contributor.authorFreeman, Daryl
dc.contributor.authorGruffydd-Jones, Kevin
dc.contributor.authorCopland, Anne
dc.contributor.authorGodley, Clifford
dc.contributor.authorChisholm, Alison
dc.contributor.authorThomas, Mike
dc.date.accessioned2014-10-13T10:13:01Z
dc.date.available2014-10-13T10:13:01Z
dc.date.issued2013-11-07
dc.identifier.citationPrice , D , Ryan , D , Burden , A , Von Ziegenweidt , J , Gould , S , Freeman , D , Gruffydd-Jones , K , Copland , A , Godley , C , Chisholm , A & Thomas , M 2013 , ' Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care ' , Clinical and Translational Allergy , vol. 3 , no. 1 , pp. 37 . https://doi.org/10.1186/2045-7022-3-37en
dc.identifier.issn2045-7022
dc.identifier.otherPURE: 42389516
dc.identifier.otherPURE UUID: 6eda6bb2-aedb-4232-b863-6499ed1ea709
dc.identifier.otherPubMed: 24195942
dc.identifier.otherScopus: 85006085633
dc.identifier.urihttp://hdl.handle.net/2164/3712
dc.descriptionAcknowledgements We thank Robin Taylor for his informative thinking and publications on FeNO, which have helped to influence and direct the thinking of the authors. Funding Extraction of the real-life dataset was funded by Research in Real Life Limited, the analysis of the dataset and the writing of this manuscript were co-funded (50:50) by Research in Real Life Limited and Aerocrine.en
dc.language.isoeng
dc.relation.ispartofClinical and Translational Allergyen
dc.rightshttp://www.biomedcentral.com/about/license This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0/en
dc.subjectfractional exhaled nitric oxide (FeNO)en
dc.subjectpractical guidanceen
dc.subjectdiagnosisen
dc.subjecton-going asthma managementen
dc.subjectsteroid-responsive diseaseen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleUsing fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine careen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/2045-7022-3-37


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record